“Rifaximin Versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients Having Cirrhosis of Liver”. Medical Forum Monthly, vol. 28, no. 12, May 2024, https://medicalforummonthly.com/index.php/mfm/article/view/4304.